Biosynthesis of the third and fifth complement components by isolated human lung cellsROTHMAN, B. L; MERROW, M; BAMBA, M et al.The American review of respiratory disease. 1989, Vol 139, Num 1, pp 212-220, issn 0003-0805, 9 p.Article

Mechanisms of complement activation by cristalline cholesterolVOGT, W; VON ZABERN, I; DAMERAU, B et al.Molecular immunology. 1985, Vol 22, Num 2, pp 101-106, issn 0161-5890Article

Carbohydrate composition of the second, third and fifth components and factors B and D of human complementTOMANA, M; NIEMANN, M; GARNER, C et al.Molecular immunology. 1985, Vol 22, Num 2, pp 107-111, issn 0161-5890Article

Alterations in C3, C4, factor B, and related metabolites in septic shockLIN, R. Y; ASTIZ, M. E; SAXON, J. C et al.Clinical immunology and immunopathology (Print). 1993, Vol 69, Num 2, pp 136-142, issn 0090-1229Article

A NEW FUNCTION OF THE ACTIVATED THIRD COMPONENT OF COMPLEMENT: BINDING TO C5, AN ESSENTIAL STEP FOR C5 ACTIVATION.VOGT W; SCHMIDT G; VON BUTTLAR B et al.1978; IMMUNOLOGY; G.B.; DA. 1978; VOL. 34; NO 1; PP. 29-40; BIBL. 16 REF.Article

Vaccin reconstituant contre l'hépatite virale B. Influence de l'antigène de surface HBS sur le complément C3 et C5MAKI, E; NAGAMI, K; MOTEGI, K et al.Yakuri to chiryo. 1987, Vol 15, Num 6, pp 71-77, issn 0386-3603Article

Plasmin activity and complement activation during storage of citrated platelet concentratesBODE, A. P; MILLER, D. T; NEWMAN, S. L et al.The Journal of laboratory and clinical medicine. 1989, Vol 113, Num 1, pp 94-102, issn 0022-2143Article

Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formationHEINEN, Stefan; HARTMANN, Andrea; MIHLAN, Michael et al.Blood. 2009, Vol 114, Num 12, pp 2439-2447, issn 0006-4971, 9 p.Article

Tissue distribution of complement regulatory membrane proteins in ratsFUNABASHI, K; OKADA, N; MATSUO, S et al.Immunology (Oxford). 1994, Vol 81, Num 3, pp 444-451, issn 0019-2805Article

ISOLATION AND CHARACTERIZATION OF THE THIRD AND FIFTH COMPONENTS OF RABBIT COMPLEMENTGICLAS PC; KEELING PJ; HENSON PM et al.1981; MOL. IMMUNOL.; ISSN 0161-5890; GBR; DA. 1981; VOL. 18; NO 2; PP. 113-123; BIBL. 15 REF.Article

PRESERVATION OF C3, C5 AND C5A FUNCTIONAL ACTIVITIES BY A NEW RADIOLABELING METHOD; DEMONSTRATION OF C5 PRODUCTS IN COMPLEMENT-ACTIVATED SERUMKREUTZER DL; KUNKEL S; WARD PA et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 5; PP. 2278-2282; BIBL. 14 REF.Article

FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3aINAGI, R; MIYATA, T; MAEDA, K et al.Immunology letters. 1991, Vol 27, Num 1, pp 49-52, issn 0165-2478, 4 p.Article

C3 REQUIREMENTS FOR FORMATION OF ALTERNATIVE PATHWAY C5 CONVERTASE.DAHA MR; FEARON DT; AUSTEN KF et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 2; PP. 630-634; BIBL. 23 REF.Article

Does nephritic factor related to the disease activityin hypocomplementemic membranoproliferative glomerulonephritis ?OHI, H; TANUMA, Y.Nephron. 1992, Vol 62, Num 1, issn 0028-2766, p. 116Article

INCOMPATIBILITY BETWEEN COMPLEMENT COMPONENTS C3 AND C5 OF GUINEA-PIG AND MAN, AN INDUCTION OF THEIR INTERACTION IN C5 ACTIVATION BY CLASSICAL AND ALTERNATIVE C5 CONVERTASESVON ZABERN I; NOLTE R; VOGT W et al.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 9; NO 1; PP. 69-74; BIBL. 19 REF.Article

Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophiliaPIERANGELI, Silvia S; GIRARDI, Guillermina; VEGA-OSTERTAG, Mariano et al.Arthritis and rheumatism. 2005, Vol 52, Num 7, pp 2120-2124, issn 0004-3591, 5 p.Article

Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndromeZILOW, G; JOKA, T; OBERTACKE, U et al.Critical care medicine. 1992, Vol 20, Num 4, pp 468-473, issn 0090-3493Article

Use of ionic-hydrophobic sorbents to separate the C3, C4, and C5 components of the complement from the normal serum in human bloodSOLOV'EVA, L. Y; ANTIPOVA, T. O; ISHCHENKO, A. M et al.Russian journal of physical chemistry. 1991, Vol 65, Num 10, pp 1508-1511, issn 0036-0244Conference Paper

Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISALARSSON, A; SJOQUIST, J.Journal of immunological methods. 1989, Vol 119, Num 1, pp 103-109, issn 0022-1759, 7 p.Article

Anaphylatoxin levels in human aqueous humorMONDINO, B. J; SUMNER, H.Investigative ophthalmology & visual science. 1986, Vol 27, Num 8, pp 1288-1292, issn 0146-0404Article

The effects of metal ions and temperature on the interaction of cobra venom factor and human complement factor BHENSLEY, P; O'KEEFE, M. C; SPANGLER, C. J et al.The Journal of biological chemistry (Print). 1986, Vol 261, Num 24, pp 11038-11044, issn 0021-9258Article

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of functionROUMENINA, Lubka T; FRIMAT, Marie; MOUSSON, Christiane et al.Blood. 2012, Vol 119, Num 18, pp 4182-4191, issn 0006-4971, 10 p.Article

Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway―mediated diseasesFRIDKIS-HARELI, Masha; STOREK, Michael; MAZSAROFF, Istvan et al.Blood. 2011, Vol 118, Num 17, pp 4705-4713, issn 0006-4971, 9 p.Article

Structure and function of decay accelerating factor CD55NICHOLSON-WELLER, A; CE WANG.The Journal of laboratory and clinical medicine. 1994, Vol 123, Num 4, pp 485-491, issn 0022-2143Article

Cytokine regulation of C3 and C5 production by human corneal fibroblastROTHMAN, B; DESPINS, A; WEBB, S et al.Experimental eye research. 1991, Vol 53, Num 3, pp 353-361, issn 0014-4835Article